PharmiWeb.com - Global Pharma News & Resources
04-Jul-2019

Antacids Market to Reach Approximately USD 8.4 Billion by 2026

The Global Antacids Market Size is expected to reach USD 8.4 Billion by 2026 and growing CAGR around 4.4 % during the forecast period from 2018 to 2026.

The Global Antacids Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/1045

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Antacids Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Antacids Market?
  • What is the market drivers, restrains, opportunities governing the global Antacids Market?
  • Which is the largest and the fastest growing segments in the global Antacids Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Antacids Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues.

The major players associated with the Antacids Market are Procter amp; Gamble; GlaxoSmithKline plc; Pfizer Inc.; Bayer AG; Takeda Pharmaceutical Company Limited; Boehringer Ingelheim International GmbH; Sun Pharmaceuticals Ltd.; Dr. Reddyrsquo;s Laboratories Ltd.; Reckitt Benckiser Group plc; and Sanofi.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1045

The Major Market Segments of GlobalAntacids Marketare as below:

Market Segmentation

Market By Dosage Form

  • Tablet
  • Liquid
  • Others

Market By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America is assessed to be the second biggest developing portion. This was credited to expanding stomach related confusion pervasiveness combined with purchaser attention to acid neutralizer product. In 2017, as indicated by the CDC, the quantity of visits in crisis offices with stomach related framework infections as the essential analysis was around 32.3 million. Moreover, the nearness of developed economies inside the region is adding fuel to its development in this region.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Antacids
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Antacids Market By Dosage Form
1.2.2.1. Global Antacids Market Revenue and Growth Rate Comparison By Dosage Form (2015-2026)
1.2.2.2. Global Antacids Market Revenue Share By Dosage Form in 2017
1.2.2.3. Tablet
1.2.2.4. Liquid
1.2.2.5. Others
1.2.3. Antacids Market By Distribution Channel
1.2.3.1. Global Antacids Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.3.2. Global Antacids Market Revenue Share By Distribution Channel in 2017
1.2.3.3. Retail Pharmacy
1.2.3.4. Hospital Pharmacy
1.2.3.5. Online Pharmacy
1.2.3.6. Others
1.2.4. Antacids Market by Geography
1.2.4.1. Global Antacids Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Antacids Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Antacids Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Antacids Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Antacids Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Antacids Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Antacids Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Antacids Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Antacids Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Antacids Major Manufacturers in 2017

CHAPTER 4. ANTACIDS MARKET BY DOSAGE FORM

4.1. Global Antacids Revenue By Dosage Form
4.2. Tablet
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Liquid
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ANTACIDS MARKET BY DISTRIBUTION CHANNEL

5.1. Global Antacids Revenue By Distribution Channel
5.2. Retail Pharmacy
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Hospital Pharmacy
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Online Pharmacy
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA ANTACIDS MARKET BY COUNTRY

6.1. North America Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Antacids Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Antacids Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE ANTACIDS MARKET BY COUNTRY

7.1. Europe Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Antacids Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC ANTACIDS MARKET BY COUNTRY

8.1. Asia-Pacific Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Antacids Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA ANTACIDS MARKET BY COUNTRY

9.1. Latin America Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Antacids Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST ANTACIDS MARKET BY COUNTRY

10.1. Middle East Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Antacids Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA ANTACIDS MARKET BY COUNTRY

11.1. Africa Antacids Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Antacids Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Dosage Form, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Procter amp; Gamble
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. laxoSmithKline plc
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Pfizer Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Bayer AG
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Takeda Pharmaceutical Company Limited
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. BoehringerIngelheim International GmbH
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Sun Pharmaceuticals Ltd.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Dr. Reddyrsquo;s Laboratories Ltd.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Reckitt Benckiser Group plc
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Sanofi
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1045

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 04-Jul-2019